DOCSLIB.ORG

Annual Report 2012 Faysal Bank Annual Report 2012 35 INCOME and EXPENSE COMPOSITION STATEMENT of FINANCIAL POSITION COMPOSITION

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2012 Faysal Bank Annual Report 2012 35 INCOME and EXPENSE COMPOSITION STATEMENT of FINANCIAL POSITION COMPOSITION SIX YEARS FINANCIAL SUMMARY SIX YEARS FINANCIAL SUMMARY (Rupees in million) (Rupees in million) 2012 2011 2010 2009 2008 2007 2012 2011 2010 2009 2008 2007 OPERATIONAL RESULTS CASHFLOWS Mark-up / return / interest earned 28,802 28,825 19,710 16,958 13,404 11,611 Operating activities (4,767) 5,912 8,882 17,862 1,882 7,262 Mark-up / return / interest expensed 19,839 19,619 13,919 11,968 8,455 7,459 Investing activities 7,654 (5,842) 2,050 (18,438) (2,669) (5,505) Fee, commission, brokerage & FX Income 2,627 2,624 1,659 1,286 1,161 1,058 Financing activities (204) (209) 3,004 (5) (1,326) (818) Dividend and Capital gains 1,646 363 1,675 1,493 1,073 2,337 Cash & cash equivalents at end of the year 25,694 23,011 23,150 9,214 9,804 11,380 Total income 14,245 13,277 9,804 7,803 7,260 7,593 Provisions / Write-off 1,401 695 2,202 2,192 2,047 2,079 MATURITY PROFILE Operating expenses 11,004 11,103 6,775 4,311 3,416 2,816 Net assets maturity wise: Operating profit / (loss) before tax and provision 3,241 2,173 3,029 3,492 3,844 4,777 Upto one month (28,399) (28,640) (77,873) (71,637) (41,840) (30,936) Profit / (loss) before taxation 1,840 1,478 827 1,301 1,797 2,698 Over one month to three months 8,976 (3,212) 17,346 (10,549) 10,431 2,301 Profit / (loss) after taxation 1,423 1,280 1,190 1,200 1,115 2,272 Over three months to six months 3,729 12,261 8,387 29,493 3,048 6,981 Dividends % - - - - - 25.0 Over six months to one year 30,994 29,662 (5,960) 9,557 803 2,443 Bonus shares % 12.5 12.5 20.0 - 15.0 25.0 Over one year to two years (2,525) (17,458) 18,886 12,839 12,407 17,083 Over two years to three years 5,052 (139) 5,727 10,746 7,316 5,235 BALANCE SHEET Over three years to five years (3,349) 12,261 22,848 12,931 5,316 5,370 Shareholders’ equity 18,729 17,793 16,643 11,336 10,136 10,345 Over five years to ten years (1,275) 4,736 17,006 14,923 6,596 3,970 Revaluation Reserves 2,249 1,420 (125) 1,447 636 5,811 Deposits 240,713 214,615 195,315 123,665 102,777 102,067 Over ten years 7,774 9,743 10,149 4,480 6,695 3,710 Borrowings from financial institutions 35,568 39,697 34,636 34,986 13,027 9,996 Total net assets 20,978 19,214 16,516 12,783 10,772 16,157 Advances - net of provision 172,299 148,162 133,707 91,346 83,512 87,346 Investments - net of provision 87,995 93,409 86,419 56,531 36,153 31,553 Total assets 313,064 292,568 267,321 180,865 138,241 141,277 OTHERS Imports 120,269 103,766 73,116 66,400 38,089 68,171 Exports 83,525 69,033 44,646 36,173 50,395 52,110 FINANCIAL RATIOS Capital Adequacy ratio % 10.75 10.65 10.31 11.93 10.84 10.27 Profit before tax ratio % 6.39 5.13 4.20 7.67 13.41 23.24 Gross spread ratio (Net mark up income / gross mark-up income) % 31.12 31.94 29.38 29.43 36.92 35.75 Income / Expense ratio Times 1.29 1.20 1.45 1.81 2.13 2.70 Return on Capital Employed % 1.16 1.31 0.80 9.00 10.57 11.34 Return on Average Equity (ROE) % 7.79 7.43 8.51 11.18 10.89 23.33 Return on Average Assets (ROA) % 0.47 0.46 0.53 0.75 0.80 1.77 CASA to total deposits % 60.92 54.50 53.22 54.51 47.68 43.85 Weighted Average Cost of Deposit % 6.37 7.04 6.70 8.23 7.03 7.00 Current Ratio Times 0.98 0.73 0.68 0.51 0.54 0.65 Gross Advances / Deposit Ratio (Average) % 78.26 77.25 78.25 82.58 87.69 94.80 Net Advances / Deposit Ratio (Average) % 70.38 68.76 70.55 77.22 83.41 91.69 Non-performing loans to Gross advances ratio % 14.44 15.74 16.34 10.85 8.40 5.22 Specific provision held / Non-performing loans ratio % 66.31 65.51 69.46 62.45 65.14 67.33 Total assets turnover ratio / Fixed assets turnover ratio (Total assets / Fixed assets) Times 28.83 26.96 30.63 64.87 52.23 56.17 Price Earning ratio % 6.94 5.89 12.15 13.54 9.58 26.92 Earning per share (EPS) * Rs. 1.53 1.38 1.28 1.30 1.20 2.45 Net Assets per share Rs. 22.62 23.31 22.60 20.99 20.34 30.50 Market value per share Rs. 10.65 8.13 15.59 17.53 11.51 65.95 Market value per share - high Rs. 14.12 15.95 20.90 18.75 66.70 80.25 Market value per share - low Rs. 8.38 8.07 12.97 7.94 11.51 60.00 Earning Asset to Total Asset Ratio % 83.20 83.39 83.28 90.06 89.51 91.17 Dividend Yield Ratio (Cash Dividend) % - - - - - 3.79 Dividend pay out ratio (Cash Dividend) % - - - - - 102.04 Book value per share - excluding surplus/ (deficit) on revaluation of assets Rs. 20.20 21.59 22.77 18.61 19.14 19.53 Book value per share - excluding surplus on revaluation of fixed assets Rs. 20.64 20.98 22.60 20.99 20.34 30.51 Book value per share - including surplus/ (deficit) on revaluation of assets Rs. 22.62 23.31 20.99 20.34 30.51 Number of employees 3,465 3,435 3,582 2,042 1,929 1,759 Number of branches 265 257 226 133 129 105 * Adjusted for prior years to reflect bonus shares issued during 2012 34 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 35 INCOME AND EXPENSE COMPOSITION STATEMENT OF FINANCIAL POSITION COMPOSITION Income Composition Rupees in Million 16,000 14,000 2,627 Assets Liabilities & Equity Shareholders' Equity 12,000 2,624 10,000 9% 1,659 4% 0% 8,000 1,058 1% 17% 1,286 1,161 8% 6% 14% 6,000 11,618 10,653 1% 0% 8,145 28% 4,000 11% 20% 6,535 6,517 Expense Composition 6,099 55% 77% 49% 2,000 Rupees in Million - 12,000 2007 2008 2009 2010 2011 2012 Fund Based Income 10,000 5,140 5,025 Fee, Commission, Brokerage and FX Income 8,000 6,000 3,075 5,979 4,000 2,051 5,963 Advances Deposits & other accounts Share Capital 1,602 Cash & Bank Balances Borrowing from Financial Institutions Statutory Reserve 2,000 1,493 3,700 2,260 Other assets Revaluation Reserve Share Premium 1,323 1,814 - Investments Sub-ordinated loans Reserve arising on amalgamation Unappropriated Profit 2007 2008 2009 2010 2011 2012 Lending to Financial Institutions Shareholders’ equity Other Liabilities Other Cost Employee Cost 36 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 37 ADVANCES SEGMENT INFORMATION Advances Categorisation 0% Advances 3% 4% 93% Gross Advances Rupees in Million 190,851 Loans, Cash Credits and 200,000 Running Finances 165,483 Net Investment in Finance Lease 180,000 151,206 Bills Discounted & Purchased 160,000 Reverse Repo Transactions 140,000 120,000 98,384 91,016 100,000 88,621 80,000 60,000 40,000 Advances by Currency 20,000 2% - 98% 2007 2008 2009 2010 2011 2012 Chemical and Pharmaceuticals Textile Sugar Ready made garments Automobile and transportation equipment Oil Refining / Marketing Electronics and electrical appliances Iron and Steel Synthetic and Rayon Individuals Transportation, Road and Air Others Agriculture Cement Construction Footwear and leather garments Financial Distribution / Trading Production and transmission of energy Food and Allied Paper and Board Local currency Foreign currencies Telecommunication Mining and Quarrying 38 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 39 DEPOSITS SEGMENT INFORMATION Deposits Categorisation Deposits Deposits Rupees in Million 27% 240,713 250,000 38% 214,615 4% 195,315 200,000 31% 150,000 123,655 Savings 102,067 102,777 Term 100,000 Current and margin accounts Financial Institutions 50,000 - Deposits by Currency 2007 2008 2009 2010 2011 2012 10% 90% Chemical and Phamaceuticals Synthetic and Rayon Automobile and transportation equipment Construction Mining and Quarrying Production and transmission of energy Oil Refining / Marketing Textile Individuals Food and Allied Footwear and leather garments Sugar Transportation, Road and Air Electronics and electrical appliances Financial Agriculture Paper and Board Iron and Steel Local currency Ready made garments Others Telecommunication Distribution / Trading Cement Foreign currencies 40 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 41 TOTAL ASSETS AND NET ADVANCES TO DEPOSITS INVESTMENTS Investments Total Assets Net Advances to Deposits Rupees in Million Rupees in Million Rupees in Million Investments 240,713 250,000 5% 350,000 313,064 214,615 292,568 100,000 93,409 195,315 87,995 6% 300,000 267,321 200,000 86,419 172,299 90,000 89% 250,000 148,162 80,000 150,000 133,707 200,000 180,865 123,665 70,000 56,531 138,241 102,067 102,777 60,000 141,277 91,346 150,000 100,000 87,346 83,512 50,000 36,153 100,000 40,000 50,000 31,553 50,000 30,000 20,000 - - 2007 2008 2009 2010 2011 2012 2007 2008 2009 2010 2011 2012 10,000 Advances Net Deposits - 2007 2008 2009 2010 2011 2012 Government Securities Shares / Other Units TFCs / Bonds 42 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 43 EQUITY EPS AND MATURITY PROFILE Earning Per Share In Rupees 2.45 2.50 Paid-up Capital Shareholders' Equity 2.00 Rupees in Million Rupees in Million 1.53 1.50 1.30 1.28 1.38 9,274 1.20 10,000 1.00 9,000 8,243 18,729 Maturity Profile 17,793 20,000 Percentage 8,000 7,309 16,643 18,000 0.50 7,000 6,091 16,000 6,000 5,296 5,296 14,000 11,337 - 10,344 10,136 25 5,000 12,000 2007 2008 2009 2010 2011 2012 4,000 10,000 20 20 8,000 20 3,000 6,000 14 14 15 2,000 4,000 15 13 1,000 10 11 11 11 2,000 9 8 10 9 10 10 8 - - 2007 2008 2009 2010 2011 2012 2007 2008 2009 2010 2011 2012 5 4 1 - Upto 1 months Over 1 month Over 3 months Over 6 months Over 1 year to Over 2 years to Over 3 years to Over 5 years to Over 10 years to 3 months to 6 months to 1 year 2 years 3 years 5 years 10 years Liabilities Assets 44 Faysal Bank Annual Report 2012 Faysal Bank Annual Report 2012 45 STOCK PRICE FINANCIAL RESULTS Profit before Tax Profit after Tax FBL Share Price Movement 2012 vs 2011 Rupees in Million Rupees in Million 18.00 3,000 2,500 16.00 2,698 2,272 2,500 14.00 2,000 1,840 12.00 2,000 1,796 1,423 1,478 1,280 1,500 1,200 1,190 1,115 10.00 1,500 1,301 Share Price 8.00 827 1,000 1,000 6.00 500 500 4.00 - -
Load more

Recommended publications
  • GSK Q1 Report 2021
    Calibrating Precision GSK Pakistan Limited FirstAnnual Quarter Report Report 20212020 CORPORATE INFORMATION As at March 31, 2021 Board of Directors Management Committee Disclosure Committee Mr. Dmytro Oliinyk Ms. Erum Shakir Rahim Ms. Erum Shakir Rahim Chairman Chief Executive Officer Chairperson Ms. Erum Shakir Rahim Mr. Abdul Samad* Mr. Abdul Samad* Chief Executive Officer Chief Financial Officer Member Mr. Abdul Samad* Mehar-e-daraksha Ameer Mr. Dmytro Oliinyk Chief Financial Officer Legal Director Member Ms. Maheen Rahman Dr. Tariq Farooq Mehar-e-daraksha Ameer Independent Director Business Unit Director BU 1 Member Mr. Muneer Kamal Syed Nasir Farid** Company Secretary Independent Director Business Unit Director BU 2 Ms. Mehar-e-daraksha Ameer Mr. Mehmood Mandviwalla Dr. Naved Masoom Ali Non-Executive Director Business Unit Director BU 3 Chief Financial Officer Mr. Mark Dawson Khurram Amjad Mr. Abdul Samad* Non-Executive Director Director Commercial Chief Internal Auditor Excellence & CTC Audit Committee Syed Ahsan Ejaz Dr. Gohar Nayab Khan Mr. Muneer Kamal Regulatory Affairs Cluster Bankers Chairman Head - Pakistan & Iran Citibank NA Mr. Dmytro Oliinyk Mr. Abdul Haseeb Pirzada Deutsche Bank A.G. Member Director Corporate Affairs and Habib Bank Limited Administration Meezan Bank Limited Mr. Mark Dawson Standard Chartered Bank (Pakistan) Ltd Member Mr. Zain Anjum Country Compliance Officer Auditors Mr. Mehmood Mandviwalla Member Dr. Yousuf Hasan Khan Yousuf Adil & Co. Chartered Director Medical Accountants Ms. Maheen Rahman Member Syed Nabigh Raza Alam Legal Advisors Tech Head Hashmi & Hashmi Human Resource Mr. Obaid Siddiqui Faisal, Mahmood Ghani and Co & Remuneration Head of Procurement Legal Consultancy Inc. Committee Mr. Farqaleet Iqbal Registered Office Mr.
    [Show full text]
  • GSK Annual Report 2016
    Annual Report Transcending boundaries is in our DNA. This is evident in how we continue to discover, develop and bring to market, new medicines and vaccines to address the unmet needs of healthcare providers and their patients. As a responsible healthcare company, we drive change by adopting new and innovative methodologies, aligned with our values, so that we can better serve the evolving needs of our society and enable more patients to benefit from our medicines. We firmly believe that keeping the patient at the heart of everything we do is integral to our success; inspiring us to continue on this journey and transcend boundaries. GSK Contents 002 026 062 Our Vision, Mission and Core Vaccines Key Operating and Financial Data Values 028 065 004 Primary Care Direct Cash Flow Statement Corporate Information 030 066 006 Specialty Business Unit Horizontal Analysis Financial Highlights 031 067 007 Medical Affairs Vertical Analysis DUPONT Analysis 032 070 008 Awards 2016 Statement of Compliance with the The GSK Story 034 Code of Corporate Governance 010 Global Manufacturing & Supply 072 GSK Expectations (GMS) Review Report to the Members 011 035 073 Strategic Priorities Warehousing and Auditors Report to the Members 012 Distribution (W&D) 074 Company Profile & 036 Balance Sheet Group Structure Environment Health & Safety (EHS) 075 014 Profit and Loss Account Our Behaviour 038 Quality Management System (QMS) 076 015 Cash Flow Statement Organogram 040 Corporate Social Responsibility 077 016 (CSR) Statement of Changes in Equity Geographical Presence
    [Show full text]
  • OICCI CSR Report 2018-2019
    COMBINING THE POWER OF SOCIAL RESPONSIBILITY Corporate Social Responsibility Report 2018-19 03 Foreword CONTENTS 05 OICCI Members’ CSR Impact 06 CSR Footprint – Members’ Participation In Focus Areas 07 CSR Footprint – Geographic Spread of CSR Activities 90 Snapshot of Participants’ CSR Activities 96 Social Sector Partners DISCLAIMER The report has been prepared by the Overseas Investors Chamber of Commerce and Industry (OICCI) based on data/information provided by participating companies. The OICCI is not liable for incorrect representation, if any, relating to a company or its activities. 02 | OICCI FOREWORD The landscape of CSR initiatives and activities is actively supported health and nutrition related initiatives We are pleased to present improving rapidly as the corporate sector in Pakistan has through donations to reputable hospitals, medical care been widely adopting the CSR and Sustainability camps and health awareness campaigns. Infrastructure OICCI members practices and making them permanent feature of the Development was also one of the growing areas of consolidated 2018-19 businesses. The social areas such as education, human interest for 65% of the members who assisted communi- capital development, healthcare, nutrition, environment ties in the vicinity of their respective major operating Corporate Social and infrastructure development are the main focus of the facilities. businesses to reach out to the underprivileged sections of Responsibility (CSR) the population. The readers will be pleased to note that 79% of our member companies also promoted the “OICCI Women” Report, highlighting the We, at OICCI, are privileged to have about 200 leading initiative towards increasing level of Women Empower- foreign investors among our membership who besides ment/Gender Equality.
    [Show full text]
  • UPL Annual Report 2019
    Unilever Pakistan Foods Limited Annual Report 2019 Contents Vision & Core Values 02 Company Information 03 Directors’ Profile 04 Chairman's Review 06 Directors’ Report 08 Board Meetings Attendance 14 Board Committee Meetings Held During the Year 14 Performance Indicators for 6 years 16 Statement of Financial Postion - Analysis for 6 years 19 Profit or Loss Account and other Comprehensive 21 Income - Analysis for 6 years Statement of Wealth Generated and Distributed 23 Pattern of Shareholding 24 Statement of Compliance with 26 the Code of Corporate Governance Independent Auditor's Review Report 27 Financial Statements 29 Notice of Annual General Meeting 79 Form of Proxy 85 Dividend Mandate Form 87 Vision Unilever Pakistan Foods Limited - Annual Report 2019 Our vision is to grow our business, while decoupling our environmental footprint from our growth and increasing our positive social impact. Core Values Impeccable Wowing our Integrity Consumers & We are honest, transparent Customers and ethical in our dealings We win the hearts and minds of at all times. our consumers and customers. Living an Demonstrating a Enterprise Culture Passion for Winning We believe in trust, and We deliver what we promise. outstanding teamwork. We value a creative & fun environment. Bringing out the Making a Best in All of Us Better World We are empowered leaders, who We care about and are inspired by new challenges actively contribute to and have a bias for action. the community in which we live. 02 Company Information Unilever Pakistan Foods Limited - Annual Report 2019 Board of Directors Mr. Kamran Y. Mirza Independent Director & Chairman of the Board Mr.
    [Show full text]
  • Issue 40: Summer 2009/10
    Journal of the Melbourne Cricket Club Library Issue 40, Summer 2009 This Issue From our Summer 2009/10 edition Ken Williams looks at the fi rst Pakistan tour of Australia, 45 years ago. We also pay tribute to Richie Benaud's role in cricket, as he undertakes his last Test series of ball-by-ball commentary and wish him luck in his future endeavours in the cricket media. Ross Perry presents an analysis of Australia's fi rst 16-Test winning streak from October 1999 to March 2001. A future issue of The Yorker will cover their second run of 16 Test victories. We note that part two of Trevor Ruddell's article detailing the development of the rules of Australian football has been delayed until our next issue, which is due around Easter 2010. THE EDITORS Treasures from the Collections The day Don Bradman met his match in Frank Thorn On Saturday, February 25, 1939 a large crowd gathered in the Melbourne District competition throughout the at the Adelaide Oval for the second day’s play in the fi nal 1930s, during which time he captured 266 wickets at 20.20. Sheffi eld Shield match of the season, between South Despite his impressive club record, he played only seven Australia and Victoria. The fans came more in anticipation games for Victoria, in which he captured 24 wickets at an of witnessing the setting of a world record than in support average of 26.83. Remarkably, the two matches in which of the home side, which began the game one point ahead he dismissed Bradman were his only Shield appearances, of its opponent on the Shield table.
    [Show full text]
  • Glaxosmithkline Pakistan Limited Half Yearly Report 2018 Corporate Information
    GlaxoSmithKline Pakistan Limited Half Yearly Report 2018 Corporate Information Board of Directors Mr. Muhammad Imran Amin Mr. Andrew Aristidou Chairman Country Compliance Officer Mr. M. Azizul Huq Chief Executive Officer Dr. Yousuf Khan* Mr. Abdul Samad Chief Financial Officer Director Medical Mr. Husain Lawai Independent Director Mr. Mehmood Mandviwalla Non-Executive Director Mr. Sohail Matin Non-Executive Director Company Secretary Mr. Mark Dawson Non-Executive Director Syed Azeem Abbas Naqvi Audit Committee Chief Financial Officer Mr. Husain Lawai Chairman Mr. Abdul Samad Mr. Mehmood Mandviwalla Member Mr. Andrew Aristidou Member Mr. Mark Dawson Member Chief Internal Auditor Syed Ahsan Ejaz Human Resource & Remuneration Committee Mr. Mehmood Mandviwalla Chairman Bankers Mr. Husain Lawai Member Citibank NA Mr. M. Azizul Huq Member Deutsche Bank A.G. Mr. Andrew Aristidou Member Habib Bank Limited Meezan Bank Limited Standard Chartered Bank (Pakistan) Ltd Management Committee Mr. M. Azizul Huq Chief Executive Officer Auditors Deloitte Yousuf Adil & Co. Chartered Accountants Mr. Abdul Samad Chief Financial Officer Legal Advisors Syed Azeem Abbas Naqvi Cluster Legal Director - Pakistan, Iran & Bangladesh Mandviwalla & Zafar Hashmi & Hashmi Dr. Naved Masoom Ali Faisal, Mahmood Ghani and Co Business Unit Director -Primary Care Legal Consultancy Inc. Dr. Tariq Farooq Business Unit Director - Speciality Registered Office Khurram Amjad 35 - Dockyard Road, West Wharf, Director Commercial Excellence Karachi - 74000. Dr. Gohar Nayab Khan Tel: 92-21-111-475-725 Director Regulatory Affairs (111-GSK-PAK) Fax: 92-21-32314898, 32311122 Mr. Abdul Haseeb Pirzada Website: www.gsk.com.pk Head of Corporate Affairs and Administration Mr. Ahmad Ali Zia HR Cluster Head - Pakistan and Iran *Mr.
    [Show full text]
  • Josephitenewsletter
    1 JosephiteNewsletter Volume 13 | Issue 3 | St Joseph’s College (Autonomous), Bangalore- 27 | January - March 2020 birth certificates that are the to confront this emergency daily obsessions of the powers together, and find innovative that be, have sharper relevance ways to take our unfinished work now in the wake of the pandemic forward. caused by the coronavirus. We see markets crashing, people When we look at our institution’s in panic, and misinformation history, we will find many everywhere. instances in the past when the Josephite spirit has been tested, In these dark times, we must each and has responded in abundance. find an internal compass that This, too, is an opportunity for us must guide us. If we look within, to forget small differences and we will find the discernment that rise to the challenge of being will guide us to the necessary human. next step. At the fag end of the semester, at a time reserved for Principal’s Note goodbyes to those leaving the institution, we must instead focus In my last message, I spoke of on staying safe, and on the well- how simple acts of nature can being of our loved ones. remind us of the fragility of human presence on this planet. We do not know what the next Those remarks, made in the few weeks might bring, but let context of focusing on serious us resolve first to rally around the issues like climate change rather institutional ideals of faith and than the trivia of ancestry and toil. Let us be strong in our resolve 1 2 2 College Events Republic Day Protocol in charge: Mr.
    [Show full text]
  • Annual Report 2008 Find out More About GSK Online…
    Do more, feel better, live longer Grow Deliver Simplify Annual Report 2008 Find out more about GSK online… www.gsk.com Website GlaxoSmithKline’s website www.gsk.com gives additional information on the Group. Information made available on the website does not constitute part of this Annual Report. Notice regarding limitations on Director liability under English Law Under the UK Companies Act 2006, a safe harbour limits the liability of Directors in respect of statements in and omissions from the Report of the Directors contained on pages 12 to 98. Under English law the Directors would be liable to the company (but not to any third party) if the Report of the Directors contains errors as a result of recklessness or knowing misstatement or dishonest concealment of a material fact, but would not otherwise be liable. Report of the Directors Pages 12 to 98 inclusive consist of a Report of the Directors that has been drawn up and presented in accordance with and in reliance upon English company law and the liabilities of the Directors in connection with that report shall be subject to the limitations and restrictions provided by such law. Cautionary statement regarding forward-looking statements The Group’s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including this document and written information released, or oral statements made, to the public in the future by or on behalf of the Group, may contain forward-looking statements. Forward-looking statements give the Group’s current expectations or forecasts of future events. A shareholder can identify these statements by the fact that they do not relate strictly to historical or current facts.
    [Show full text]
  • Kifayah Market Insights 28 April 2021
    DAILY MARKET INSIGHTS 28-Apr-2021 Change Index points KMI 30 INDEX PERFORMANCE OVERVIEW PKR % Change Closing KMI 30 Index (437) 72,955 Contributing shares Closing Price - Rs. Oil & Gas Development Company Limited (2.42) (2.56) (135.40) 92.29 Pakistan Petroleum Limited (1.56) (1.84) (90.14) 83.19 Lucky Cement Limited (6.05) (0.70) (67.87) 854.12 KMI 30 INDEX VOLUMES Today 42 5 days average 58 59 14 days average Millions Source: https://formerdps.psx.com.pk/ & Calculations of Kifayah Investment Management Limited Top most buyer Top most seller PORTFOLIO INVESTMENT SUMMARY Other Organization Foreign Corporates Amount (Net) 566,619,364 (592,631,016) Buying / Selling sector wise composition Commercial Banks 85.94% 61.50% All other Sectors 5.20% 0.63% Technology and Communication 3.03% 8.32% Cement 0.13% 13.06% Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily FOREIGN PORTFOLIO INVESTMENT TREND Today (242) (163) 5 days average 20 14 days average Millions Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily & Calculations of Kifayah Investment Management Limited MATERIAL INFORMATION Disclosure of Interest by a Substantial Shareholder, bought 3,950 shares at the average Packages Limited price of Rs. 473.19 each on 27 April 2021. The Company is pleased to announce the facility registration of its two new facilities from U.S. Food & Drug Administration duly verified by Registrar Corp, Virginia, USA. The Searle Company Limited This registration will enable Searle Company to export its consumer products, Dietary and Nutritional Supplements to the USA Makret.
    [Show full text]
  • Baby Autonomies
    Autonomy Baby Country Parent Country Owned Petrobras Argentina Argentina Petrobras Brazil 67% Ypf Argentina Repsol Ypf Spain 58% British American Tobacco Bangladesh Bangladesh BAT UK 65% Lafarge Surma Cement Bangladesh Lafarge France 29% Barclays Bank of Botswana Botswana Barclays UK 68% Ambev Brazil AB-InBev Belgium 62% Aes Tiete Brazil Aes Corp USA 32% Tractebel Energia Brazil Gdf Suez France 69% Cia De Transmissao De Ene Brazil Interconexion Electrica Colombia 54% Tim Participacoes Brazil Telecom Italia Italy 77% Vivo Participacoes Brazil Telefonica Spain 35% Telecomunicacoes De Sao Brazil Telefonica Spain 37% British American Tobacco Chile Chile BAT UK 96% Embotelladoras Coca-Cola Polar Chile Coca-Cola USA 100% CCU Chile Heineken Netherlands 66% Telefonica Chile Chile Telefonica Spain 98% Aes Gener Chile Aes Corp USA 54% Empresa Nacional De Electric Chile Enel Italy 60% Exito Colombia Casino France 54% SOLIBRA Cote d'Ivoire Castel France 72% Nestlé Cote d'Ivoire Cote d'Ivoire Nestlé Switzerland 81% Unilever Cote d'Ivoire Cote d'Ivoire Unilever UK 90% Komercni Banka Czech Societe Generale France 60% Telefónica Czech Republic Czech Telefonica Spain 69% GlaxoSmithKline (Egypt) Egypt Glaxosmithkline UK 91% Guinness Ghana Ghana Diageo UK 51% Unilever Ghana Ghana Unilever UK 66% Coca-Cola Hellenic Bottling Greece Coca-Cola USA AEON Credit Service Asia Hong Kong Aeon Co Japan Magyar Telekom Telecommunica Hungary Deutsche Telekom Germany 59% Colgate Palmolive India India Colgate Palmolive USA 51% Goodyear India India Goodyear Tire & Rubber
    [Show full text]
  • Value-At-Risk and Expected Stock Returns: Evidence from Pakistan
    The Lahore Journal of Economics 19 : 2 (Winter 2014): pp. 71–100 Value-at-Risk and Expected Stock Returns: Evidence from Pakistan Javed Iqbal* and Sara Azher** Abstract This study investigates whether exposure to downside risk, as measured by value-at-risk (VaR), explains expected returns in an emerging market, i.e., Pakistan. We find that portfolios with a higher VaR are associated with higher average returns. In order to explore the empirical performance of VaR at the portfolio level, we use a time series approach based on 25 size and book-to-market portfolios. Based on monthly portfolio data for October 1992 to June 2008, the results show that VaR has greater explanatory power than the market, size, and book-to-market factors. Keywords: Value-at-risk, emerging market, Fama-French factors. JEL classification: C32, G32. 1. Introduction The most important implications of the capital asset pricing model (CAPM) (see Sharpe, 1964; Lintner, 1969; Black, Jensen, & Scholes, 1972) are that (i) the expected return on a risky asset is linearly and positively related to its systematic risk, and (ii) only the asset’s beta captures cross- sectional variations in expected stock returns; other variables have no explanatory power. However, the empirical evidence of the last few decades suggests that many alternative risk and nonrisk variables are able to explain average stock returns. These include size (Banz, 1981), the ratio of book equity to market equity (Fama & French, 1992, 1993, 1995, 1996; Stattman, 1980; Rosenberg, Reid, & Lanstein, 1985; Chan, Hamao, & Lakonishok, 1991), the price/earnings ratio (Basu, 1977), leverage (Bhandari, 1988), liquidity (Pastor & Stambaugh, 2003), and value-at-risk (VaR) (Bali & Cakici, 2004; Chen, Chen, & Chen, 2010).
    [Show full text]
  • DAILY MARKET INSIGHTS 28-Oct-19
    DAILY MARKET INSIGHTS 28-Oct-19 Change Index points KSE 100 INDEX PERFORMANCE OVERVIEW PKR % Change Closing KSE 100 Index 204 33,862 Contributing shares Closing Price - Rs. Lucky Cement Limited. 10.03 2.91 28.53 354.85 Habib Bank Limited.(XD) 1.66 1.31 26.77 128.21 Bank Al-Habib Ltd. 1.31 1.94 20.81 69.01 Source: https://formerdps.psx.com.pk/ KSE 100 INDEX VOLUMES Today 91 5 days average 80 110 14 days average Millions Source: https://formerdps.psx.com.pk/ & Calculations of Kifayah Investment Management Limited Top most buyer Top most seller PORTFOLIO INVESTMENT SUMMARY Individuals Foreign Corporates Amount (Net) 289,502,409 (148,295,774) Buying / Selling sector wise composition All other Sectors 40.74% 7.94% Cement 23.02% 37.79% Oil and Gas Marketing Companies 13.69% 0.00% Commercial Banks 3.45% 26.49% Oil and Gas Exploration Companies 5.06% 24.31% Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily FOREIGN PORTFOLIO INVESTMENT TREND Today (177) 18 5 days average (49) 14 days average Millions Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily & Calculations of Kifayah Investment Management Limited MATERIAL INFORMATION Packages Limited Disclosure of Interest by Executive; purchased 25,000 shares at Rs. 290 each. Hi-tech Lubricants Disclosure of Interest by Executive; purchased 35,000 shares at Rs. 28.93 each. Source: https://dps.psx.com.pk/announcements/companies CONSOLIDATED (where applicable) RESULTS and Growth over same Quarter EPS (Qtr.) EPS DPS ANNOUNCEMENTS EPS Gross
    [Show full text]